Hossein Khiabanian
Overview
Explore the profile of Hossein Khiabanian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
4468
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeeshan S, Dalal B, Arauz R, Zingone A, Harris C, Khiabanian H, et al.
Oncogene
. 2025 Jan;
PMID: 39789165
Lung cancer is one of the most frequently diagnosed cancers in the US. African-American (AA) men are more likely to develop lung cancer with higher incidence and mortality rates than...
2.
Simhadri S, Carrick J, Murphy S, Kothari O, Al-Hraishami H, Kulkarni A, et al.
JCO Precis Oncol
. 2024 Dec;
8:e2300260.
PMID: 39626159
Purpose: Combined BRAF, MEK, and EGFR inhibition can induce clinical responses in BRAF-V600E-mutant colon cancer, but rapid resistance often occurs. Methods: We use serial monitoring of circulating tumor DNA cell-free...
3.
Singh A, Khiabanian H
BMC Bioinformatics
. 2024 Jul;
25(1):248.
PMID: 39080559
Normalization is a crucial step in the analysis of single-cell RNA-sequencing (scRNA-seq) counts data. Its principal objectives are reduction of systematic biases primarily introduced through technical sources and transformation of...
4.
Singh A, Khiabanian H
bioRxiv
. 2024 Feb;
PMID: 38328133
Normalization is a crucial step in the analysis of single-cell RNA-sequencing (scRNA-seq) counts data. Its principal objectives are to reduce the systematic biases primarily introduced through technical sources and to...
5.
Lancho O, Singh A, da Silva-Diz V, Aleksandrova M, Khatun J, Tottone L, et al.
Blood Cancer Discov
. 2022 Nov;
4(1):12-33.
PMID: 36322781
Significance: We identify a T-ALL axis whereby NOTCH1 activates SIRT1 through an enhancer region, and SIRT1 deacetylates and activates KAT7. Targeting SIRT1 shows antileukemic effects, partly mediated by KAT7 inactivation....
6.
Bal E, Kumar R, Hadigol M, Holmes A, Hilton L, Loh J, et al.
Nature
. 2022 Oct;
611(7934):E2.
PMID: 36253470
No abstract available.
7.
Deshpande M, Paniza T, Jalloul N, Nanjangud G, Twarowski J, Koren A, et al.
Mol Cell
. 2022 Sep;
82(20):3781-3793.e7.
PMID: 36099913
Germline mutations in the BRCA genes are associated with a higher risk of carcinogenesis, which is linked to an increased mutation rate and loss of the second unaffected BRCA allele...
8.
Bal E, Kumar R, Hadigol M, Holmes A, Hilton L, Loh J, et al.
Nature
. 2022 Jul;
607(7920):808-815.
PMID: 35794478
Diffuse large B cell lymphoma (DLBCL) is the most common B cell non-Hodgkin lymphoma and remains incurable in around 40% of patients. Efforts to sequence the coding genome identified several...
9.
Jalloul N, Ganesan S, Garber J, Khiabanian H
JCO Precis Oncol
. 2022 Jun;
6:e2200188.
PMID: 35709401
No abstract available.
10.
Farmanbar A, Firouzi S, Kneller R, Khiabanian H
J Transl Med
. 2022 Feb;
20(1):65.
PMID: 35109853
Background: Revealing the impacts of endogenous and exogenous mutagenesis processes is essential for understanding the etiology of somatic genomic alterations and designing precise prognostication and treatment strategies for cancer. DNA...